Literature DB >> 25016068

EEG abnormalities and seizures in genetically diagnosed Fragile X syndrome.

Takijah T Heard1, Sriram Ramgopal1, Jonathan Picker2, Sharyn A Lincoln2, Alexander Rotenberg1, Sanjeev V Kothare3.   

Abstract

We describe the seizure and EEG characteristics in a population of children with known Fragile X. The medical records of 135 genetically confirmed FXS patients receiving care in a Fragile X clinic and their available EEG reports were reviewed. The mean age was 5.94 years old including 18 males and 1 female. The mean age was 4-9 years old with an age range of 15 months to 13 years old. Twenty-two patients (16.3%) in the series had parent-reported behavior suspicious of seizures. Sixteen patients (14.1%, 1 female) had at least one EEG recorded for evaluation of clinical events suspicious for seizure, and three patients (2.2%) had an EEG in the context of a polysomnography for diagnosing sleep apnea. The mean age at EEG evaluation was 6.0 years (standard deviation 3.8 years). EEG findings included slowing of background rhythm (n=9) and epileptiform discharges (n=7). Four patients had normal EEGs (n=4). Six patients (4.4% of the sample population) were diagnosed with epilepsy by both clinical seizure semiology and documented EEG abnormalities. Thirteen patients (68.4% of total) had episodes of staring and behavioral arrest with no EEG correlate, indicating non-epileptic events. Of the eight patients who underwent a repeat EEG, five patients had showed normalization in the posterior dominant rhythm over time, two patients had unchanged findings and one patient had worsening of his EEG. Our data warrant further prospective validation.
Copyright © 2014. Published by Elsevier Ltd.

Entities:  

Keywords:  EEG; Fragile X syndrome

Mesh:

Year:  2014        PMID: 25016068     DOI: 10.1016/j.ijdevneu.2014.07.002

Source DB:  PubMed          Journal:  Int J Dev Neurosci        ISSN: 0736-5748            Impact factor:   2.457


  19 in total

Review 1.  Excitatory/Inhibitory Balance and Circuit Homeostasis in Autism Spectrum Disorders.

Authors:  Sacha B Nelson; Vera Valakh
Journal:  Neuron       Date:  2015-08-19       Impact factor: 17.173

Review 2.  Altered Neuronal and Circuit Excitability in Fragile X Syndrome.

Authors:  Anis Contractor; Vitaly A Klyachko; Carlos Portera-Cailliau
Journal:  Neuron       Date:  2015-08-19       Impact factor: 17.173

3.  FMRP regulates multipolar to bipolar transition affecting neuronal migration and cortical circuitry.

Authors:  Giorgio La Fata; Annette Gärtner; Nuria Domínguez-Iturza; Tom Dresselaers; Julia Dawitz; Rogier B Poorthuis; Michele Averna; Uwe Himmelreich; Rhiannon M Meredith; Tilmann Achsel; Carlos G Dotti; Claudia Bagni
Journal:  Nat Neurosci       Date:  2014-11-17       Impact factor: 24.884

4.  Autism Spectrum Disorder in Fragile X Syndrome: Cooccurring Conditions and Current Treatment.

Authors:  Walter E Kaufmann; Sharon A Kidd; Howard F Andrews; Dejan B Budimirovic; Amy Esler; Barbara Haas-Givler; Tracy Stackhouse; Catharine Riley; Georgina Peacock; Stephanie L Sherman; W Ted Brown; Elizabeth Berry-Kravis
Journal:  Pediatrics       Date:  2017-06       Impact factor: 7.124

5.  Lovastatin suppresses hyperexcitability and seizure in Angelman syndrome model.

Authors:  Leeyup Chung; Alexandra L Bey; Aaron J Towers; Xinyu Cao; Il Hwan Kim; Yong-Hui Jiang
Journal:  Neurobiol Dis       Date:  2017-10-31       Impact factor: 5.996

Review 6.  Human Models Are Needed for Studying Human Neurodevelopmental Disorders.

Authors:  Xinyu Zhao; Anita Bhattacharyya
Journal:  Am J Hum Genet       Date:  2018-12-06       Impact factor: 11.025

Review 7.  Modeling fragile X syndrome in the Fmr1 knockout mouse.

Authors:  Tatiana M Kazdoba; Prescott T Leach; Jill L Silverman; Jacqueline N Crawley
Journal:  Intractable Rare Dis Res       Date:  2014-11

Review 8.  Channelopathies in fragile X syndrome.

Authors:  Pan-Yue Deng; Vitaly A Klyachko
Journal:  Nat Rev Neurosci       Date:  2021-04-07       Impact factor: 34.870

9.  Evaluation of lorcaserin as an anticonvulsant in juvenile Fmr1 knockout mice.

Authors:  Tanishka S Saraf; Daniel E Felsing; Jessica L Armstrong; Raymond G Booth; Clinton E Canal
Journal:  Epilepsy Res       Date:  2021-05-27       Impact factor: 2.991

10.  ER stress-induced modulation of neural activity and seizure susceptibility is impaired in a fragile X syndrome mouse model.

Authors:  Dai-Chi Liu; Kwan Young Lee; Simon Lizarazo; Jessie K Cook; Nien-Pei Tsai
Journal:  Neurobiol Dis       Date:  2021-07-23       Impact factor: 7.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.